Philippe Toussaint

Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial

J. Guigay, Anne Aupérin, Jérôme Fayette et al. · The Lancet Oncology · 2021 · 232 citations

Medicine, Oncology, Chemotherapy +14

Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancer

Pierre-Étienne Heudel, Sylvie Chabaud, David Pérol et al. · ESMO Open · 2021 · 34 citations · Full text

Medicine, Immunology, Oncology +11

Alterations in Homologous Recombination-Related Genes and Distinct Platinum Response in Metastatic Triple-Negative Breast Cancers: A Subgroup Analysis of the ProfiLER-01 Trial

Elise Bonnet, Véronique Haddad, Stanislas Quesada et al. · Journal of Personalized Medicine · 2022 · 13 citations · Full text

Medicine, Genetics, Oncology +17

Real-World Experience of Bevacizumab as First-Line Treatment for Ovarian Cancer: The GINECO ENCOURAGE Cohort of 468 French Patients

Dominique Berton, Anne Floquet, W. Lescaut et al. · Frontiers in Pharmacology · 2021 · 11 citations · Full text

Medicine, Gynecology, Oncology +14